The treatment of eye melanoma using protons is considered a therapeutic standard. There are historical experiences, started in 1975 in Boston, and since then this has been practice therapy in selected centres, which have collected over the years a substantial experience on about 12,000 patients.
Improvement of the techniques over time has allowed to progressively reduce the risk of complications, reducing the risk of relapses, of removal of the organ, besides a lower incidence of retinopathy and cataracts.
Proton therapy for ocular melanoma offers excellent possibilities to preserve the eye by treating the target with maximum precision and with the maximum preservation of the normal tissue. In just 4 sessions therapy is thus completed.
Preservation of vision
Assistance in ophthalmology
Minimizing the negative effects
Return to life immediately after the treatment